Sertraline-augmented lithium therapy of organic mood syndrome.
Workman
E A
EA
Harrington
D P
DP
D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications; D005260:Female; D006760:Hospitalization; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D020280:Sertraline
D017366:Serotonin Receptor Agonists; D015057:1-Naphthylamine; D008094:Lithium; D020280:Sertraline